Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.

Elon Musk's brain-chip company, Neuralink, plans to implant its innovative Blindsight chip into a human for the first time in 2025, representing a significant advancement in medical technology.

Elon Musk’s brain chip company, Neuralink, is aiming to achieve a major medical milestone by the end of 2025 with the first human implantation of its artificial visual prosthesis, Blindsight.